Associated Papers
Population-based estimates of the global prevalence and carrier frequency of apparent mineralocorticoid excess caused by 11β-hydroxysteroid dehydrogenase type 2 deficiency.
Charoenngam N et al.
Orphanet Journal of Rare Diseases, 2025
41316338 (PubMed )
Supplement: 13023_2025_4160_MOESM1_ESM.docx
Diagnosing apparent mineralocorticoid excess in a child with hypertension and nephrocalcinosis: from symptoms to genetics.
Vallabhaneni P et al.
Cen Case Reports, 2025
Summary of Known Genetic and Epigenetic Modification Contributed to Hypertension.
Pratamawati TM et al.
International Journal of Hypertension, 2023
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics.
Lu YT et al.
Journal of Translational Medicine, 2022
A Rare Cause of Chronic Hypokalemia with Metabolic Alkalosis: Case Report and Differential Diagnosis.
Bertulli C et al.
Children (basel, Switzerland), 2020
Select a paper to view details